Skip to Content
Merck
CN
All Photos(1)

Documents

1096586

USP

Carglumic Acid

United States Pharmacopeia (USP) Reference Standard

Synonym(s):

N-Carbamyl-L-glutamic acid

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C6H10N2O5
CAS Number:
1188-38-1
Molecular Weight:
190.15
MDL number:
MFCD00047874
UNSPSC Code:
41116107
PubChem Substance ID:
329749237
NACRES:
NA.24

grade

pharmaceutical primary standard

manufacturer/tradename

USP

application(s)

pharmaceutical

format

neat

storage temp.

2-8°C

SMILES string

NC(=O)N[C@@H](CCC(O)=O)C(O)=O

InChI

1S/C6H10N2O5/c7-6(13)8-3(5(11)12)1-2-4(9)10/h3H,1-2H2,(H,9,10)(H,11,12)(H3,7,8,13)/t3-/m0/s1

InChI key

LCQLHJZYVOQKHU-VKHMYHEASA-N

Gene Information

human ... CPS1(1373)

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Application



  • Efficacy of Carglumic Acid in Nutritional Management of N-Acetylglutamate Synthase Deficiency: A study evaluated the effectiveness of Carglumic Acid in the nutritional management of patients with N-Acetylglutamate Synthase deficiency, showing significant improvements in patient outcomes (Singh et al., 2024).


  • Real-World Use of Carglumic Acid for Organic Acidurias: An observational study highlighted the real-world application of Carglumic Acid in treating methylmalonic and propionic acidurias, demonstrating beneficial effects in metabolic management (Yap et al., 2024).


  • Management of Hyperammonemia in Postpartum Women: Research documented a case of partial N-acetyl glutamate synthase deficiency presenting as postpartum hyperammonemia, with management strategies involving Carglumic Acid (Abou Haidar et al., 2023).


  • Genetic Insights from Carglumic Acid Treatment: Research on novel compound heterozygote variants in the CPS1 gene emphasized the lessons learned from clinical management using Carglumic Acid, impacting late onset carbamoyl phosphate synthetase 1 deficiency (Lin et al., 2022).


Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

USP issued SDS can be found here.

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service